Authors:
GORE M
MAINWARING P
AHERN R
MACFARLANE V
SLEVIN M
HARPER P
OSBORNE R
MANSI J
BLAKE P
WILTSHAW E
SHEPHERD J
Citation: M. Gore et al., RANDOMIZED TRIAL OF DOSE-INTENSITY WITH SINGLE-AGENT CARBOPLATIN IN PATIENTS WITH EPITHELIAL OVARIAN-CANCER, Journal of clinical oncology, 16(7), 1998, pp. 2426-2434
Citation: Wm. Liu et al., EFFECTS OF HEMATOPOIETIC GROWTH-FACTORS IN COMBINATION WITH ETOPOSIDEON SISTER-CHROMATID EXCHANGE FREQUENCIES IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS, Cancer chemotherapy and pharmacology, 41(4), 1998, pp. 343-346
Citation: M. Slevin et al., ANGIOGENIC OLIGOSACCHARIDES OF HYALURONAN INDUCE PROTEIN-TYROSINE KINASE-ACTIVITY IN ENDOTHELIAL-CELLS AND ACTIVATE A CYTOPLASMIC SIGNAL-TRANSDUCTION PATHWAY RESULTING IN PROLIFERATION, Laboratory investigation, 78(8), 1998, pp. 987-1003
Citation: M. Slevin, CHARITY HAS PUBLISHED INFORMATION BOOKLET ABOUT CLINICAL-TRIALS IN CANCER, BMJ. British medical journal, 314(7073), 1997, pp. 76-76
Authors:
KRUPINSKI J
ISSA R
BUJNY T
SLEVIN M
KUMAR P
KUMAR S
KALUZA J
Citation: J. Krupinski et al., A PUTATIVE ROLE FOR PLATELET-DERIVED GROWTH-FACTOR IN ANGIOGENESIS AND NEUROPROTECTION AFTER ISCHEMIC STROKE IN HUMANS, Stroke, 28(3), 1997, pp. 564-573
Citation: M. Slevin et al., RETINOPATHY OF PREMATURITY SCREENING, STRESS-RELATED RESPONSES, THE ROLE OF NESTING, British journal of ophthalmology, 81(9), 1997, pp. 762-764
Authors:
MAINWARING PN
NICOLSON MC
HICKISH T
PENSON R
JOEL S
SLEVIN M
SMITH IE
Citation: Pn. Mainwaring et al., CONTINUOUS INFUSIONAL TOPOTECAN IN ADVANCED BREAST AND NON-SMALL-CELLLUNG-CANCER - NO EVIDENCE OF INCREASED EFFICACY, British Journal of Cancer, 76(12), 1997, pp. 1636-1639
Authors:
GORE ME
RUSTIN G
SLEVIN M
GALLAGHER C
PENSON R
OSBORNE R
LEDERMANN J
CAMERON T
THOMPSON JM
Citation: Me. Gore et al., SINGLE-AGENT PACLITAXEL IN PATIENTS WITH PREVIOUSLY UNTREATED STAGE-IV EPITHELIAL OVARIAN-CANCER, British Journal of Cancer, 75(5), 1997, pp. 710-714
Citation: M. Slevin et al., THE GANGLIOSIDE GM(3) IS RAISED IN THE SERA AND TISSUE OF PATIENTS WITH BLADDER-TUMORS, International journal of oncology, 8(2), 1996, pp. 271-274
Citation: M. Slevin et al., THE GANGLIOSIDE PROFILE OF HUMAN BLADDER CELL-LINES AND THE EFFECT OFEXOGENOUS GANGLIOSIDES ON THEIR GROWTH, International journal of oncology, 8(2), 1996, pp. 275-281
Authors:
ARNOTT SJ
CUNNINGHAM D
GALLAGHER J
GRAY R
HARDCASTLE J
HOUGHTON J
JAMES RD
LENNON TA
MEADOWS HM
MOSSMAN J
NORTHOVER JMA
MORGAN DAL
PLOWMAN PN
SLEVIN M
Citation: Sj. Arnott et al., EPIDERMOID ANAL CANCER - RESULTS FROM THE UKCCCR RANDOMIZED TRIAL OF RADIOTHERAPY ALONE VERSUS RADIOTHERAPY, 5-FLUOROURACIL, AND MITOMYCIN, Lancet, 348(9034), 1996, pp. 1049-1054
Authors:
GALLAGHER CJ
ORAM DH
JEYARAJAH AR
OLIVER RTD
BLAKE P
SLEVIN M
Citation: Cj. Gallagher et al., GONADOTROPIN-RELEASING-HORMONE ANALOGUE(GNRHA) TREATMENT FOR RECURRENT PROGESTAGEN RESISTANT ENDOMETRIAL CANCER, British Journal of Cancer, 74, 1996, pp. 16-16
Authors:
SLEVIN M
MOSSMAN J
BOWLING A
LEONARD R
STEWARD W
HARPER P
MCILLMURRAY M
THATCHER N
Citation: M. Slevin et al., VOLUNTEERS OR VICTIMS - PATIENTS VIEWS OF RANDOMIZED CANCER CLINICAL-TRIALS, British Journal of Cancer, 71(6), 1995, pp. 1270-1274
Authors:
CUNNINGHAM D
PAZARES L
MILAN S
POWLES R
NICOLSON M
HICKISH T
SELBY P
TRELEAVAN J
VINER C
MALPAS J
SLEVIN M
FINDLAY M
RAYMOND J
GORE ME
Citation: D. Cunningham et al., HIGH-DOSE MELPHALAN AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION AS CONSOLIDATION IN PREVIOUSLY UNTREATED MYELOMA, Journal of clinical oncology, 12(4), 1994, pp. 759-763
Authors:
PITTMAN K
PERREN T
WARD U
PRIMROSE J
SLEVIN M
PATEL N
SELBY P
Citation: K. Pittman et al., PHARMACOKINETICS OF 5-FLUOROURACIL IN COLORECTAL-CANCER PATIENTS RECEIVING INTERFERON, Annals of oncology, 4(6), 1993, pp. 515-516
Authors:
OSBORNE R
JOEL S
GREBENIK K
TREW D
SLEVIN M
Citation: R. Osborne et al., THE PHARMACOKINETICS OF MORPHINE AND MORPHINE GLUCURONIDES IN KIDNEY FAILURE, Clinical pharmacology and therapeutics, 54(2), 1993, pp. 158-167
Authors:
PERREN TJ
WILTSHAW E
HARPER P
SLEVIN M
STEIN R
TAN S
GORE M
FRYATT IJ
BLAKE PR
Citation: Tj. Perren et al., A RANDOMIZED STUDY OF CARBOPLATIN VS SEQUENTIAL IFOSFAMIDE CARBOPLATIN FOR PATIENTS WITH FIGO STAGE-III EPITHELIAL OVARIAN-CARCINOMA, British Journal of Cancer, 68(6), 1993, pp. 1190-1194
Authors:
DOWNER S
JOEL S
ALLBRIGHT A
PLANT H
STUBBS L
TALBOT D
SLEVIN M
Citation: S. Downer et al., A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF MEDROXYPROGESTERONE ACETATE (MPA) IN CANCER CACHEXIA, British Journal of Cancer, 67(5), 1993, pp. 1102-1105
Authors:
KJORSTAD K
HARRIS A
BERTELSEN K
SLEVIN M
SCHULTZ H
HELLMAN K
JANSSENS N
MARTIN A
CANETTA R
Citation: K. Kjorstad et al., A MULTICENTER PHASE-II STUDY OF CARBOPLATIN IN ADVANCED OVARIAN-CARCINOMA - FINAL REPORT, Annals of oncology, 3(3), 1992, pp. 217-222